Effects of OPRM1 and DRD2 on Brain Structure in Drug-naïve Adolescents: Genetic and Neural Vulnerabilities to Substance Use

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2021 Nov 24

PMID 34816289

Citations 1

Authors

Giorgia Picci

Diana H Fishbein

John W VanMeter

Emma J Rose

Affiliations

Soon will be listed here.

Abstract

Genetic variants in the opioid receptor mu 1 (OPRM1) and dopamine receptor d2 (DRD2) genes are implicated in behavioral phenotypes related to substance use disorders (SUD). Despite associations among OPRM1 (rs179971) and DRD2 (rs6277) genes and structural alterations in neural reward pathways implicated in SUDs, little is known about the contribution of risk-related gene variants to structural neurodevelopment. In a 3-year longitudinal study of initially SU-naïve adolescents (N = 129; 70 females; 11-14 years old), participants underwent an MRI structural scan at baseline and provided genetic assays for OPRM1 and DRD2 with SU behavior assessed during follow-up visits. Baseline differences in key reward-related brain regions (i.e., bilateral caudate and cingulate cortex) were detected in those with genetic liability for SU in OPRM1 who went onto engage in SU at subsequent waves of data collection. In addition, main effects of OPRM1, DRD2, and SU were related to variability in structure of the putamen, anterior cingulate, and nucleus accumbens, respectively. These data provide preliminary evidence that genetic risk factors interact with future SU to confer structural variability prior to SU in regions commonly implicated in risk for SU and the development of SUDs.

Citing Articles

Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.

White O, Roeder N, Blum K, Eiden R, Thanos P Int J Environ Res Public Health. 2022; 19(15).

PMID: 35954830 PMC: 9368674. DOI: 10.3390/ijerph19159477.

References

Bach P, Vollsta Dt-Klein S, Kirsch M, Hoffmann S, Jorde A, Frank J . Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects. Eur Neuropsychopharmacol. 2015; 25(8):1128-35. DOI: 10.1016/j.euroneuro.2015.04.013. View

Batalla A, Lorenzetti V, Chye Y, Yucel M, Soriano-Mas C, Bhattacharyya S . The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users. Cannabis Cannabinoid Res. 2018; 3(1):1-10. PMC: 5797324. DOI: 10.1089/can.2017.0021. View

Behrendt S, Wittchen H, Hofler M, Lieb R, Beesdo K . Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation?. Drug Alcohol Depend. 2008; 99(1-3):68-78. DOI: 10.1016/j.drugalcdep.2008.06.014. View

Brody G, Chen Y, Beach S . Differential susceptibility to prevention: GABAergic, dopaminergic, and multilocus effects. J Child Psychol Psychiatry. 2013; 54(8):863-71. PMC: 3771493. DOI: 10.1111/jcpp.12042. View

Carskadon M, Acebo C . A self-administered rating scale for pubertal development. J Adolesc Health. 1993; 14(3):190-5. DOI: 10.1016/1054-139x(93)90004-9. View

Cheetham A, Allen N, Whittle S, Simmons J, Yucel M, Lubman D . Volumetric differences in the anterior cingulate cortex prospectively predict alcohol-related problems in adolescence. Psychopharmacology (Berl). 2014; 231(8):1731-42. DOI: 10.1007/s00213-014-3483-8. View

Cope L, Martz M, Hardee J, Zucker R, Heitzeg M . Reward activation in childhood predicts adolescent substance use initiation in a high-risk sample. Drug Alcohol Depend. 2018; 194:318-325. PMC: 6540995. DOI: 10.1016/j.drugalcdep.2018.11.003. View

Courtney K, Ghahremani D, Ray L . Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addict Biol. 2012; 18(3):593-604. PMC: 3683582. DOI: 10.1111/adb.12013. View

Ersche K, Jones P, Williams G, Turton A, Robbins T, Bullmore E . Abnormal brain structure implicated in stimulant drug addiction. Science. 2012; 335(6068):601-4. DOI: 10.1126/science.1214463. View

10.

Ersche K, Williams G, Robbins T, Bullmore E . Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience. Curr Opin Neurobiol. 2013; 23(4):615-24. DOI: 10.1016/j.conb.2013.02.017. View

11.

Faul F, Erdfelder E, Lang A, Buchner A . G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39(2):175-91. DOI: 10.3758/bf03193146. View

12.

Fischl B, Salat D, Busa E, Albert M, Dieterich M, Haselgrove C . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002; 33(3):341-55. DOI: 10.1016/s0896-6273(02)00569-x. View

13.

Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig I . DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet. 2003; 33(1):67-72. DOI: 10.1023/a:1021055617738. View

14.

Heitzeg M, Cope L, Martz M, Hardee J . Neuroimaging Risk Markers for Substance Abuse: Recent Findings on Inhibitory Control and Reward System Functioning. Curr Addict Rep. 2015; 2(2):91-103. PMC: 4520315. DOI: 10.1007/s40429-015-0048-9. View

15.

Hirvonen M, Laakso A, Nagren K, Rinne J, Pohjalainen T, Hietala J . C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse. 2009; 63(10):907-12. DOI: 10.1002/syn.20672. View

16.

Jordan C, Andersen S . Sensitive periods of substance abuse: Early risk for the transition to dependence. Dev Cogn Neurosci. 2016; 25:29-44. PMC: 5410194. DOI: 10.1016/j.dcn.2016.10.004. View

17.

Kleinjan M, Poelen E, Engels R, Verhagen M . Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex. Addict Biol. 2012; 18(6):1003-12. DOI: 10.1111/j.1369-1600.2011.00422.x. View

18.

Koob G, Volkow N . Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016; 3(8):760-773. PMC: 6135092. DOI: 10.1016/S2215-0366(16)00104-8. View

19.

Korucuoglu O, Gladwin T, Baas F, Mocking R, Ruhe H, Groot P . Neural response to alcohol taste cues in youth: effects of the OPRM1 gene. Addict Biol. 2016; 22(6):1562-1575. DOI: 10.1111/adb.12440. View

20.

Kravitz A, Tomasi D, LeBlanc K, Baler R, Volkow N, Bonci A . Cortico-striatal circuits: Novel therapeutic targets for substance use disorders. Brain Res. 2015; 1628(Pt A):186-98. PMC: 9364041. DOI: 10.1016/j.brainres.2015.03.048. View